Your browser does not support the NLM PubReader view.
Go to this page to see a list of supported browsers
or return to the
regular view.
Books
?
Prev
Page 0 of 0
Next
PrevNext
Done
NCBI Bookshelf
HomeBrowse All Titles Share on Facebook Share on Twitter
Done
Table of Content
The National Academies Collection: Reports funded by National Institutes of HealthTitle InformationTable of Contents Page
Done
Settings
A-A+
AUTO
Switch to classic viewPDF (8.6M)Print View
Done
Help
HelpSend us feedbackAbout PubReader
✘
Previous Page
Next Page
✘
◀▶

Learning from SARS

  • THE NATIONAL ACADEMIES
  • FORUM ON MICROBIAL THREATS
  • BOARD ON GLOBAL HEALTH
  • Reviewers
  • Preface
  • Summary and Assessment
    • OVERVIEW OF THE SARS EPIDEMIC
    • THE IMPACT OF THE SARS EPIDEMIC
    • THE PUBLIC HEALTH RESPONSE TO SARS
    • CORONAVIRUS RESEARCH AND SARS
    • BUILDING DEFENSES AGAINST A REEMERGENCE OF SARS
    • LESSONS FROM SARS FOR FUTURE OUTBREAKS
    • REFERENCES
  • 1. SARS: Emergence, Detection, and Response
    • OVERVIEW
    • THE WHO RESPONSE TO SARS AND PREPARATIONS FOR THE FUTURE
    • THE CENTERS FOR DISEASE CONTROL AND PREVENTION’S ROLE IN INTERNATIONAL COORDINATION AND COLLABORATION IN RESPONSE TO THE SARS OUTBREAK
    • ROLE OF CHINA IN THE QUEST TO DEFINE AND CONTROL SARS
    • SARS: LESSONS FROM TORONTO
    • ISOLATION AND QUARANTINE: CONTAINMENT STRATEGIES FOR SARS 2003
    • IMPACTS OF SARS ON HEALTH CARE SYSTEMS AND STRATEGIES FOR COMBATING FUTURE OUTBREAKS OF EMERGING INFECTIOUS DISEASES
    • REFERENCES
  • 2. Political Influences on the Response to SARS and Economic Impacts of the Disease
    • OVERVIEW
    • ESTIMATING THE GLOBAL ECONOMIC COSTS OF SARS
    • SARS: POLITICAL PATHOLOGY OF THE FIRST POST-WESTPHALIAN PATHOGEN
    • THE SARS EPIDEMIC AND ITS AFTERMATH IN CHINA: A POLITICAL PERSPECTIVE
    • REFERENCES
  • 3. Microbiology, Ecology, and Natural History of Coronaviruses
    • OVERVIEW
    • ANIMAL CORONAVIRUSES: LESSONS FOR SARS
    • CORONAVIRUS RESEARCH: KEYS TO DIAGNOSIS, TREATMENT, AND PREVENTION OF SARS
    • ISOLATION AND CHARACTERIZATION OF VIRUSES RELATED TO THE SARS CORONAVIRUS FROM ANIMALS IN SOUTHERN CHINA
    • REFERENCES
  • 4. Diagnostics, Therapeutics, and Other Technologies to Control SARS
    • OVERVIEW
    • EVALUATION OF REVERSE TRANSCRIPTION-PCR ASSAYS FOR RAPID DIAGNOSIS OF SEVERE ACUTE RESPIRATORY SYNDROME ASSOCIATED WITH A NOVEL CORONAVIRUS
    • NOVEL BIOSENSOR FOR INFECTIOUS DISEASE DIAGNOSTICS
    • IN VITRO ANTIVIRAL ACTIVITY OF HUMAN RHINOVIRUS 3C PROTEASE INHIBITORS AGAINST THE SARS CORONAVIRUS
    • SARS: CLEARING THE AIR
    • REFERENCES
  • 5. Preparing for the Next Disease Outbreak
    • OVERVIEW
    • ARE WE READY FOR PANDEMIC INFLUENZA?
    • MODELING A RESPONSE STRATEGY
    • REPORTING, SURVEILLANCE, AND INFORMATION EXCHANGE: THE SARS IMPERATIVE FOR INNOVATION
    • PUBLIC HEALTH LAW PREPAREDNESS
    • SARS: LESSONS FROM A NEW DISEASE
    • SARS: DOWN BUT STILL A THREAT
    • REFERENCES
  • APPENDIXES
    • Appendix A Learning from SARS: Preparing for the Next Disease Outbreak
    • Appendix B Clinical Guidance on the Identification and Evaluation of Possible SARS-CoV Disease Among Persons Presenting with Community-Acquired Illness,
    • Appendix C In the Absence of SARS-CoV Transmission Worldwide: Guidance for Surveillance, Clinical and Laboratory Evaluation, and Reporting,
    • Appendix D Selected Bibliography
    • Appendix E Glossary and Acronyms
    • Appendix F Forum Member, Speaker, and Staff Biographies